Discover the provisional program and register now!
The BHS Acute Leukemia Committee is pleased to invite hematologists, but also clinical and molecular biologists to to their symposium on "Diagnostics and Response Monitoring in Acute Leukemia in 2024" to be held on Saturday, 1 June in Hof ter Musschen (Brussels)*.
Check out the provisional program below and register now!
Molecular Diagnostics
- Introductory case presentation(s)
- Acute leukemia work-up at diagnosis: do we need to hurry?
- What is the role of new techniques in diagnostics? Optical genome mapping – RNAseq (Ph like ALL)
Lunch break
Measurable residual disease
- Introductory case presentation(s)
- Molecular MRD-monitoring: Quality control programme for molecular MRD-monitoring
- Flow MRD-monitoring
- Is there a role for MRD-monitoring in non-intensive treatment regimens in AML?
- Is there a role for MRD-monitoring in non-intensive treatment regimens in ALL?
- Is the goal MRD negativity or can we still improve on that?
* This event is not open to nurses and industry (except sponsors of this event).